The Current Consulting Group, LLC (CCG).<\/a> \u201cOne such objective common to most companies is concern for safety\u2026 Other common reasons include improving productivity; controlling the costs of doing business; increasing the overall health and well-being of employees and their families; and minimizing employee theft and other wasteful and costly behaviors.\u201d<\/p>\n\n\n\nWhatever the reason, in order for a drug testing policy to be successful, it is critical to understand all of the company objectives for your drug testing program before writing and implementing a policy. Once the policy is developed supervisor and employee training are critical to its success. And one-time training is not enough. Ongoing training and readily available support material are also critical. Without this, as we saw in the Massachusetts case, misunderstanding company policy and how it is applied can result in significant cost.<\/p>\n\n\n\n
Regular Review<\/strong><\/p>\n\n\n\nTwice and thrice over, as they say, good is it to repeat and review what is good<\/em>. – Plato<\/p>\n\n\n\n\u201cOnce a client develops their policy they assume it is once and done but that can be a costly mistake,\u201d says Sharon Bottcher, Compliance Manager at CCG. \u201cEach year there are changes to state laws and cases that impact policy compliance. An annual policy review is an important step and many employers use the policy updates as a reminder to have regular staff and management trainings \u2026 so each person understands the company\u2019s process to handle situations as they arise.\u201d<\/p>\n\n\n\n
In each of the cases in our introduction there was a breakdown in communication between recruiters, managers, supervisors, and human resources and, ultimately, a lack of adherence to the policy. In multiple cases the recruiter made commitments to applicants about the company\u2019s drug testing policy \u2013 specifically that medical marijuana use would pose no problem. However, human resources, when applying the policy, contradicted the word of the manager. When the two arms of a company\u2019s recruiting body clash, it is a clear indicator that either the company\u2019s drug testing policy lacked purpose and clarity or one of the involved parties did not understand and apply the policy. Even worse, it may mean that their policy, written, reviewed and approved, was not effectively communicated and enforced. In either case, the error opened the company to risk and with that risk, costs. Costs in time, legal fees and perhaps, fines.<\/p>\n\n\n\n
There\u2019s a test for that\u2026<\/strong><\/p>\n\n\n\nLook at situations from all angles, and you will become more open<\/em>. \u2013 Dalai Lama<\/p>\n\n\n\nOne of the biggest mistakes a company can make with its drug-free workplace policy is assuming that one size fits all. With the wave of states legalizing medical and recreational marijuana use, navigating each state\u2019s laws to ensure compliance is no longer as simple as it used to be. There is no policy wizard or template that can whip together a policy that actually responds to all the situational needs a company has. A company that assumes it is compliant or knows it was compliant when it adopted its policy several years ago is likely non-compliant today.<\/p>\n\n\n\n
There are many substance abuse testing options available to employers depending on their federal, state, and industry requirements, as well as their organizational needs. The most common test types consist of, but are not limited to, pre-employment, random, reasonable cause, post-accident, return-to-duty, and follow-up testing. Single-state companies may only have to check the laws of their home state, but need to be aware that in addition to drug testing statutes, there may be departmental regulations, workers\u2019 compensation laws, unemployment compensation laws, medical or recreational marijuana laws, and, now more than ever before, case laws. A good policy takes all of these regulations, laws and cases into account, not only to ensure legal compliance, but also to maximize return-on-investment and minimize risk. Many states\u2019 laws provide incentives to employers who maintain a drug-free workplace policy, such as workers\u2019 compensation insurance discounts, claim reductions, or protection from litigation.<\/p>\n\n\n\n
Conclusion<\/strong><\/p>\n\n\n\nAt the core of any successful drug-testing program<\/strong><\/a> is a written policy. Just as all companies are different, all policies will be different. Much depends on your company’s experience with worker substance abuse, as well as the safety-sensitive nature of the business and your company\u2019s overall organizational objectives. Your company\u2019s drug testing policy is your opportunity to clearly express your position on employee substance abuse. And an investment in a well-written, compliant policy will pay dividends in the end.<\/p>\n","protected":false},"excerpt":{"rendered":"Despite the belief that employer rights to a drug-free workplace would be protected in states where marijuana is legal, we continue to see these laws challenged in court. In Rhode Island, a judge ruled that a woman denied an internship before taking a pre-employment drug test had the right to bring suit against her would-be […]<\/p>\n","protected":false},"author":5,"featured_media":52672,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"50870,50858,50935,51354,50868,51149","_relevanssi_noindex_reason":"","footnotes":""},"categories":[45,44,47,79],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51308"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=51308"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51308\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/52672"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=51308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=51308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=51308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}